查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375949

糖組學市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途、地區和細分市場進行預測，2023-2030 年

Glycomics Market Size, Share & Trends Analysis Report By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End Use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

糖組學市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，全球糖組學市場規模預計將達到49.2億美元。

2023-2030年年複合成長率預計為14.6%。由於糖組學在各種生物過程中的重要作用，其研究和開發的擴展預計將推動全球市場的發展。此外，對個人化醫療的需求不斷成長，進一步推動了行業成長，因為糖組學在基於聚醣的診斷解決方案的開發中發揮關鍵作用。

最近，醣組學在識別疾病特異性聚醣生物標記以早期檢測和診斷各種健康狀況方面顯示出前景。聚醣生物標記的潛力引起了醫療保健和診斷行業的興趣。例如，2021 年 11 月，GlycoPath Inc. 推出了一款聚醣成像盒，用於臨床和研究樣本的糖蛋白組分析。新推出的套件具有從組織成像到生物流體分析的應用範圍，並且可以輕鬆適應多種類型的平台。

技術的進步也促進了對糖組學設備的高需求。蛋白質表徵等研究已發展成為化學和生化研究中的質譜 (MS)、高效液相層析(HPLC) 和毛細管電泳 (CE) 等先進技術。這些先進技術可提供快速、準確的結果。目前可用的糖組學技術是標準化和簡化的。

此外，支持聚醣研究的研究機構數量不斷增加是預計在不久的將來推動市場成長的主要因素。國家生物醫學糖組學中心 (NCBG) 致力於分析基因組學技術和工具的普及和開發。該中心的分析技術研究和開發項目正在開發聚醣工具、聚醣複合物和資訊學。此外，國家癌症中心由糖生物學家癌症研究聯盟組成，旨在研究聚醣的結構和功能以用於癌症研究，這就是我的意思。

糖組學市場報告亮點

  • 由於酵素在基於聚醣的研究、診斷和藥物研發中的廣泛應用，到 2022 年，酶細分市場將以 29.2% 的收益佔有率佔據行業主導地位。
  • 藥物研發和藥物開發是市場上最大的應用，由於行業參與者對開發基於聚醣的診斷的興趣日益濃厚，診斷領域預計將成長最快。
  • 在最終用途領域，學術和研究機構領域以 38.2% 的收益佔有率主導市場。收益的高成長歸因於研究中心廣泛採用聚醣結構資料分析以及出於培訓和教育目的對糖組學的日益偏好。
  • 2022年，北美地區以39.1%的收益佔有率主導全球市場。該地區的高成長是由大量研究機構的存在和政府支持法律等因素推動的。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章 產品業務分析

  • 糖組學市場：產品變異分析
  • 酵素
    • 酵素市場，2018-2030
    • 糖苷酶
    • 糖基轉移酶
    • 神經氨酸酶
    • 唾液酸轉移酶
    • 其他
  • 成套工具
    • 套件市場，2018-2030
    • 聚醣標記試劑盒
    • 聚醣精製盒
    • 聚醣釋放套件
    • 其他灰色漫畫套件
  • 試劑
    • 2018-2030年試劑市場
    • 糖蛋白
    • 單醣
    • 寡糖
    • 其他試劑
  • 裝置
    • 2018-2030年設備市場
    • 質譜儀
    • HPLC
    • MALDI-TOF
    • 陣列系統
    • 其他

第5章 按應用分類的業務分析

  • 糖組學市場：應用變化分析
  • 藥物研發發現與開發
  • 診斷
  • 其他

第6章 最終用途的業務分析

  • 糖組學市場：最終用途變異分析
  • 製藥和生物技術公司
    • 製藥和生物技術公司市場，2018-2030
  • 學術研究所
    • 學術研究機構市場，2018-2030
  • 生物製藥公司
    • 2018-2030年生物製藥公司市場
  • CRO
    • CRO市場，2018-2030

第7章 區域業務分析

  • 2022 年和 2030 年糖組學市場佔有率（按地區）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率/地位分析
  • 公司簡介/名單
    • Thermo Fisher Scientific, Inc
    • Merck KGaA
    • Agilent Technologies Inc.
    • Bruker
    • New England Biolabs
    • Shimadzu Corporation
    • Waters Corporation
    • Takara Bio Inc
    • Asparia Glycomics
    • RayBiotech Life, Inc.
Product Code: GVR-1-68038-452-9

Glycomics Market Growth & Trends:

The global glycomics market size is expected to reach USD 4.92 billion by 2030, according to a new report by Grand View Research, Inc.. The market is estimated to register a CAGR of 14.6% during 2023-2030. Growing research and development in the glycomics space, owing to its crucial role in various biological processes, is projected to drive the global market. Moreover, the increasing demand for personalized medicine has further supported industry growth as glycomics plays a significant role in developing glycan-based diagnostic solutions.

Recently glycomics have shown promise in identifying disease-specific glycan biomarkers for early detection and diagnosis of various health conditions. The potential for glycan biomarkers has attracted interest from the healthcare and diagnostics industries. For instance, in November 2021 GlycoPath Inc. launched its glycan imaging kit for glycoproteomic analysis of clinical and research samples. The newly launched kit is applicable for tissue imaging to biofluid profiling and is easily adaptable with many kinds of platforms.

Technological advancements have also contributed to the high demand for glycomics instruments. Procedures such as protein characterizations are evolving into advanced technologies such as Mass Spectrometry (MS), High-Performance Liquid Chromatography (HPLC), and Capillary Electrophoresis (CE) in chemical and biochemical research. These advanced techniques provide rapid and precise results. Glycomics technologies currently available are standardized and streamlined.

Furthermore, the increase in the number of research institutes that support glycan-based research is a major factor anticipated to fuel market growth in the near future. The National Center for Biomedical Glycomics (NCBG) focuses on the dissemination & development of technologies and tools for analytical genomics. The organization's analytical, technical R&D program involves the development of glycan tools, glycoconjugate, and informatics. In addition, the National Cancer Institute consists of the Alliance of Glycobiologists for Cancer Research, which aims at studying the structure as well as functions of glycans for cancer study.

Glycomics Market Report Highlights:

  • Enzymes segment dominated the industry in 2022 with a revenue share of 29.2% and is attributed to the wide application of enzymes in glycan-based studies, diagnostics, and drug discovery
  • Drug discovery and development is the largest application of the market, whereas the diagnostics segment is expected to witness the fastest growth owing to the growing interest of industry players in developing glycan-based diagnostics
  • In the end-use segment, the academic & research institutes segment dominated the market with a revenue share of 38.2%. The higher revenue growth is attributed to the extensive adoption of glycan structure data analysis by research centers and the increasing preference for glycomics for training & educational purposes
  • North America region dominated the global market in 2022 with a revenue share of 39.1%. The high growth of the region is governed by factors such as the presence of a large number of research institutes and supportive government legislation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definition
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective 2
    • 1.4.3. Objective 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing focus on glycomics and proteomics research
      • 3.2.1.2. Rising R & D investments by pharmaceutical and biotechnology companies
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Increasing focus on developing alternative to animal testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of glycomics instruments
      • 3.2.2.2. Stringent government policies and regulations
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Glycomics Market: Product Movement Analysis
  • 4.2. Enzymes
    • 4.2.1. Enzymes Market, 2018 - 2030 (USD Million)
    • 4.2.2. Glycosidases
      • 4.2.2.1. Glycosidases Market, 2018 - 2030 (USD Million)
    • 4.2.3. Glycosyltransferases
      • 4.2.3.1. Glycosyltransferases Market, 2018 - 2030 (USD Million)
    • 4.2.4. Neuraminidases
      • 4.2.4.1. Neuraminidases Market, 2018 - 2030 (USD Million)
    • 4.2.5. Sialyltransferases
      • 4.2.5.1. Sialyltransferases Market, 2018 - 2030 (USD Million)
    • 4.2.6. Others
      • 4.2.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. Kits
    • 4.3.1. Kits Market, 2018 - 2030 (USD Million)
    • 4.3.2. Glycan labeling kits
      • 4.3.2.1. Glycan labeling kits Market, 2018 - 2030 (USD Million)
    • 4.3.3. Glycan purification kits
      • 4.3.3.1. Glycan purification kits Market, 2018 - 2030 (USD Million)
    • 4.3.4. Glycan release kits
      • 4.3.4.1. Glycan release kits Market, 2018 - 2030 (USD Million)
    • 4.3.5. Other glycomics kits
      • 4.3.5.1. Other glycomics kits Market, 2018 - 2030 (USD Million)
  • 4.4. Reagents
    • 4.4.1. Reagents Market, 2018 - 2030 (USD Million)
    • 4.4.2. Glycoproteins
      • 4.4.2.1. Glycoproteins Market, 2018 - 2030 (USD Million)
    • 4.4.3. Monosaccharides
      • 4.4.3.1. Monosaccharides Market, 2018 - 2030 (USD Million)
    • 4.4.4. Oligosaccharides
      • 4.4.4.1. Oligosaccharides Market, 2018 - 2030 (USD Million)
    • 4.4.5. Other reagents
      • 4.4.5.1. Other reagents Market, 2018 - 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments Market, 2018 - 2030 (USD Million)
    • 4.5.2. Mass spectrometers
      • 4.5.2.1. Mass spectrometers Market, 2018 - 2030 (USD Million)
    • 4.5.3. HPLC
      • 4.5.3.1. HPLC Market, 2018 - 2030 (USD Million)
    • 4.5.4. MALDI-TOF
      • 4.5.4.1. MALDI-TOF Market, 2018 - 2030 (USD Million)
    • 4.5.5. Array systems
      • 4.5.5.1. Array systems Market, 2018 - 2030 (USD Million)
    • 4.5.6. Others
      • 4.5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Glycomics Market: Application Movement Analysis
  • 5.2. Drug Discovery & Development
    • 5.2.1. Drug Discovery & Development Market, 2018 - 2030 (USD Million)
  • 5.3. Diagnostics
    • 5.3.1. Diagnostics Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. Glycomics Market: End Use Movement Analysis
  • 6.2. Pharmaceutical & Biotechnology Companies
    • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic & Research Institutes
    • 6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 6.4. Biopharmaceutical Companies
    • 6.4.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.5. CROs
    • 6.5.1. CROs Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Glycomics Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Glycomics Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. U.S. Glycomics Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Canada Glycomics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. UK Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Germany Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. France Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Italy Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Spain Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Denmark Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Sweden Glycomics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Norway Glycomics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Japan Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. China Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. India Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Australia Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Thailand Glycomics Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. South Korea Glycomics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Glycomics Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Brazil Glycomics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Mexico Glycomics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Argentina Glycomics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. South Africa Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Saudi Arabia Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. UAE Glycomics Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Kuwait Glycomics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share/Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Agilent Technologies Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Bruker
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. New England Biolabs
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Shimadzu Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Waters Corporation
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Takara Bio Inc
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Asparia Glycomics
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. RayBiotech Life, Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 5 Global Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 6 Global Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 7 Global Glycomics Market, By Region, 2018 - 2030 (USD Million)
  • TABLE 8 North America Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 9 North America Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 10 North America Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 11 North America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 12 U.S. Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 13 U.S. Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 14 U.S. Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 15 Canada Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 16 Canada Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 17 Canada Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 18 Europe Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 19 Europe Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 20 Europe Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 21 Europe Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 22 UK Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 23 UK Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 24 UK Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
  • TABLE 25 Germany Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 26 Germany Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 27 Germany Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 28 France Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 29 France Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 30 France Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 31 Spain Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 32 Spain Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 33 Spain Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 34 Italy Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 35 Italy Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 36 Italy Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 37 Denmark Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 38 Denmark Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 39 Denmark Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 40 Norway Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 41 Norway Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 42 Norway Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 43 Sweden Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 44 Sweden Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 45 Sweden Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 46 Asia Pacific Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 47 Asia Pacific Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 48 Asia Pacific Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 49 Asia Pacific Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 50 China Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 51 China Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 52 China Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 53 Japan Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 54 Japan Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 55 Japan Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 56 India Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 57 India Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 58 India Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 60 South Korea Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 61 South Korea Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 62 Australia Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 63 Australia Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 64 Australia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 65 Thailand Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 66 Thailand Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 67 Thailand Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 68 Latin America Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 69 Latin America Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 70 Latin America Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 71 Latin America Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 72 Brazil Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 73 Brazil Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 74 Brazil Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 75 Mexico Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 76 Mexico Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 77 Mexico Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 78 Argentina Glycomics Market, By Product, 2018 - 2030 (USD Million),
  • TABLE 79 Argentina Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 80 Argentina Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 81 MEA Glycomics Market, By Country, 2018 - 2030 (USD Million)
  • TABLE 82 MEA Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 83 MEA Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 84 MEA Glycomics Market, By End-Use, 2018 - 2030 (USD Million),
  • TABLE 85 South Africa Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 86 South Africa Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 87 South Africa Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 88 UAE Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 89 UAE Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 90 UAE Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 91 Saudi Arabia Glycomics Market, By Product, 2018 - 2030 (USD Million),
  • TABLE 92 Saudi Arabia Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 93 Saudi Arabia Glycomics Market, By End-Use, 2018 - 2030 (USD Million)
  • TABLE 94 Kuwait Glycomics Market, By Product, 2018 - 2030 (USD Million)
  • TABLE 95 Kuwait Glycomics Market, By Application, 2018 - 2030 (USD Million)
  • TABLE 96 Kuwait Glycomics Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 glycomics market segmentation
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 PESTEL analysis
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Global glycomics market: Product movement analysis
  • FIG. 15 Global glycomics market, for enzymes, 2018 - 2030 (USD Million)
  • FIG. 16 Global glycomics market, for glycosidases, 2018 - 2030 (USD Million)
  • FIG. 17 Global glycomics market, for glycosyltransferases, 2018 - 2030 (USD Million)
  • FIG. 18 Global glycomics market, for neuraminidases, 2018 - 2030 (USD Million)
  • FIG. 19 Global glycomics market, for sialyltransferases, 2018 - 2030 (USD Million)
  • FIG. 20 Global glycomics market, for others, 2018 - 2030 (USD Million)
  • FIG. 21 Global glycomics market, for kits, 2018 - 2030 (USD Million)
  • FIG. 22 Global glycomics market, for glycan labeling kits, 2018 - 2030 (USD Million)
  • FIG. 23 Global glycomics market, for glycan purification kits, 2018 - 2030 (USD Million)
  • FIG. 24 Global glycomics market, for glycan release kits, 2018 - 2030 (USD Million)
  • FIG. 25 Global glycomics market, for other glycomics kits, 2018 - 2030 (USD Million)
  • FIG. 26 Global glycomics market, for reagents, 2018 - 2030 (USD Million)
  • FIG. 27 Global glycomics market, for glycoproteins, 2018 - 2030 (USD Million)
  • FIG. 28 Global glycomics market, for monosaccharides, 2018 - 2030 (USD Million)
  • FIG. 29 Global glycomics market, for oligosaccharides, 2018 - 2030 (USD Million)
  • FIG. 30 Global glycomics market, for other reagents, 2018 - 2030 (USD Million)
  • FIG. 31 Global glycomics market, for instruments, 2018 - 2030 (USD Million)
  • FIG. 32 Global glycomics market, for mass spectrometers, 2018 - 2030 (USD Million)
  • FIG. 33 Global glycomics market, for HPLC, 2018 - 2030 (USD Million)
  • FIG. 34 Global glycomics market, for MALDI-TOF, 2018 - 2030 (USD Million)
  • FIG. 35 Global glycomics market, for array systems, 2018 - 2030 (USD Million)
  • FIG. 36 Global glycomics market, for others, 2018 - 2030 (USD Million)
  • FIG. 37 Global glycomics market: Application movement analysis
  • FIG. 38 Global glycomics market, for drug discovery & development, 2018 - 2030 (USD Million)
  • FIG. 39 Global glycomics market, for diagnostics, 2018 - 2030 (USD Million)
  • FIG. 40 Global glycomics market, for others, 2018 - 2030 (USD Million)
  • FIG. 41 Global glycomics market: End Use movement analysis
  • FIG. 42 Global glycomics market, for academic & research institutes, 2018 - 2030 (USD Million)
  • FIG. 43 Global glycomics market, for pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • FIG. 44 Global glycomics market, for biopharmaceutical companies, 2018 - 2030 (USD Million)
  • FIG. 45 Global glycomics market, for CROs, 2018 - 2030 (USD Million)
  • FIG. 46 Regional marketplace: Key takeaways
  • FIG. 47 Regional outlook, 2022 & 2030
  • FIG. 48 Global glycomics market: Region movement analysis
  • FIG. 49 North America glycomics market, 2018 - 2030 (USD Million)
  • FIG. 50 U.S. glycomics market, 2018 - 2030 (USD Million)
  • FIG. 51 Canada glycomics market, 2018 - 2030 (USD Million)
  • FIG. 52 Europe glycomics market, 2018 - 2030 (USD Million)
  • FIG. 53 Germany glycomics market, 2018 - 2030 (USD Million)
  • FIG. 54 UK glycomics market, 2018 - 2030 (USD Million)
  • FIG. 55 France glycomics market, 2018 - 2030 (USD Million)
  • FIG. 56 Italy glycomics market, 2018 - 2030 (USD Million)
  • FIG. 57 Spain glycomics market, 2018 - 2030 (USD Million)
  • FIG. 58 Denmark glycomics market, 2018 - 2030 (USD Million)
  • FIG. 59 Sweden glycomics market, 2018 - 2030 (USD Million)
  • FIG. 60 Norway glycomics market, 2018 - 2030 (USD Million)
  • FIG. 61 Asia Pacific glycomics market, 2018 - 2030 (USD Million)
  • FIG. 62 Japan glycomics market, 2018 - 2030 (USD Million)
  • FIG. 63 China glycomics market, 2018 - 2030 (USD Million)
  • FIG. 64 India glycomics market, 2018 - 2030 (USD Million)
  • FIG. 65 Australia glycomics market, 2018 - 2030 (USD Million)
  • FIG. 66 South Korea glycomics market, 2018 - 2030 (USD Million)
  • FIG. 67 Thailand glycomics market, 2018 - 2030 (USD Million)
  • FIG. 68 Latin America glycomics market, 2018 - 2030 (USD Million)
  • FIG. 69 Brazil glycomics market, 2018 - 2030 (USD Million)
  • FIG. 70 Mexico glycomics market, 2018 - 2030 (USD Million)
  • FIG. 71 Argentina glycomics market, 2018 - 2030 (USD Million)
  • FIG. 72 Middle East and Africa glycomics market, 2018 - 2030 (USD Million)
  • FIG. 73 South Africa glycomics market, 2018 - 2030 (USD Million)
  • FIG. 74 Saudi Arabia glycomics market, 2018 - 2030 (USD Million)
  • FIG. 75 UAE glycomics market, 2018 - 2030 (USD Million)
  • FIG. 76 Kuwait glycomics market, 2018 - 2030 (USD Million)